So, I, I think looking at our M&A strategy, it's consistent with Vault and with all the things that we have said, we're looking to deploy between $3.5 billion and $4.5 billion between now and 2025, with a focus on things that can be strategic accelerators for us. So are there positions technologies, unique opportunities to move faster, to develop things faster Liberty and Tracepoints were really good examples of that. And we're building a pipeline of opportunities that really mirrors that it's either a unique technology or a technology mission intersection that really accelerates on our priorities. And especially around either national cyber or digital battle space, we're going to be very diligent and very assertive in terms of generating that pipeline. Liberty is done, very well since the acquisition. It's, it's a good, the integration is going well. The teams have found lots of points of touch, where we are working together, both in their core markets around health and beginning to expand across other parts of our portfolio from a COVID CR. And so forth, they reflect the rest of the business and they are because they're more civil oriented, they're seeing more of the dynamics that we see in the civil market, as opposed to the, the, the more difficult dynamics we saw most recently in defense. But I think they're, again, they're a great team. They're a great acquisition for us and they're a pattern for us to continue to follow. I -- they don't have much to add, but your question around sort of backlog to right ride through some of the, the short term cycles, obviously when we're doing due diligence, it's a variety of areas we're looking at - talent, pipeline positioning, you name it. So it's certainly in the mix, but to Tracepoint, we're not leading with that. It's still, is it on strategy, our confidence on integration it's adherence to Vault and achieving of our updated investment thesis. But yeah, for sure, we're looking at what upside do does a Company have strengthen their talent and the list goes on and on.